heart condition - GuerillaStockTrading.com https://www.guerillastocktrading.com/tag/heart-condition/ Live Free or Die Traying Fri, 30 Aug 2024 13:21:41 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.1 https://www.guerillastocktrading.com/wp-content/uploads/2020/01/cropped-cropped-dollars-32x32.png heart condition - GuerillaStockTrading.com https://www.guerillastocktrading.com/tag/heart-condition/ 32 32 28% lower risk of death, 33% risk reduction—Could this be the new standard of care for a deadly heart condition? 🤔 https://www.guerillastocktrading.com/alnylam-pharmaceuticals-deadly-heart-condition/ Fri, 30 Aug 2024 13:21:38 +0000 https://www.guerillastocktrading.com/?p=378306 Alnylam Pharmaceuticals recently presented comprehensive results from a clinical trial for its drug, vutrisiran, aimed at treating transthyretin…

This article 28% lower risk of death, 33% risk reduction—Could this be the new standard of care for a deadly heart condition? 🤔 appeared first on Guerilla Stock Trading.

]]> Cytokinetics Soars to Multi-Decade Highs with Promising Data from Aficamten Trial https://www.guerillastocktrading.com/cytokinetics-soars-to-multi-decade-highs-with-promising-data-from-aficamten-trial/ Thu, 28 Dec 2023 21:26:10 +0000 https://www.guerillastocktrading.com/?p=370141 Cytokinetics (CYTK), a leading late-stage biopharmaceutical company specializing in treatments for cardiovascular diseases, is currently experiencing a remarkable…

This article Cytokinetics Soars to Multi-Decade Highs with Promising Data from Aficamten Trial appeared first on Guerilla Stock Trading.

]]>